BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2872392)

  • 1. Bone-marrow transplantation has a limited role in prolonging second marrow remission in childhood lymphoblastic leukaemia.
    Chessells JM; Rogers DW; Leiper AD; Blacklock H; Plowman PN; Richards S; Levinsky R; Festenstein H
    Lancet; 1986 May; 1(8492):1239-41. PubMed ID: 2872392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone marrow transplantation for high-risk childhood lymphoblastic leukaemia in first remission: experience in MRC UKALL X.
    Chessells JM; Bailey C; Wheeler K; Richards SM
    Lancet; 1992 Sep; 340(8819):565-8. PubMed ID: 1355153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomised comparison of addition of autologous bone-marrow transplantation to intensive chemotherapy for acute myeloid leukaemia in first remission: results of MRC AML 10 trial. UK Medical Research Council Adult and Children's Leukaemia Working Parties.
    Burnett AK; Goldstone AH; Stevens RM; Hann IM; Rees JK; Gray RG; Wheatley K
    Lancet; 1998 Mar; 351(9104):700-8. PubMed ID: 9504514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How should acute lymphoblastic leukaemia relapsing after bone-marrow transplantation be treated?
    Barrett AJ; Joshi R; Tew C
    Lancet; 1985 May; 1(8439):1188-91. PubMed ID: 2860389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intensive therapy followed by bone marrow transplantation for patients with acute lymphocytic leukemia in second or subsequent remission: determination of prognostic factors (a report from the University of Minnesota Bone Marrow Transplantation Team).
    Woods WG; Nesbit ME; Ramsay NK; Krivit W; Kim TH; Goldman A; McGlave PB; Kersey JH
    Blood; 1983 Jun; 61(6):1182-9. PubMed ID: 6340756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of autologous and allogeneic bone marrow transplantation for treatment of high-risk refractory acute lymphoblastic leukemia.
    Kersey JH; Weisdorf D; Nesbit ME; LeBien TW; Woods WG; McGlave PB; Kim T; Vallera DA; Goldman AI; Bostrom B
    N Engl J Med; 1987 Aug; 317(8):461-7. PubMed ID: 3302708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autologous bone marrow transplantation for childhood acute lymphoblastic leukaemia in second remission - long-term follow-up.
    Vaidya SJ; Atra A; Bahl S; Pinkerton CR; Calvagna V; Horton C; Milan S; Shepherd V; Brain C; Treleaven J; Powles R; Tait D; Meller ST
    Bone Marrow Transplant; 2000 Mar; 25(6):599-603. PubMed ID: 10734293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Which treatment for childhood acute lymphoblastic leukaemia in second remission?
    Butturini A; Rivera GK; Bortin MM; Gale RP
    Lancet; 1987 Feb; 1(8530):429-32. PubMed ID: 2880224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful reinduction of patients with acute lymphoblastic leukemia who relapse following bone marrow transplantation.
    Bostrom B; Woods WG; Nesbit ME; Krivit W; Kersey J; Weisdorf D; Haake R; Goldman AI; Ramsay NK
    J Clin Oncol; 1987 Mar; 5(3):376-81. PubMed ID: 3546614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone-marrow transplantation for acute lymphoblastic leukaemia.
    Gale RP; Kersey JH; Bortin MM; Dicke KA; Good RA; Zwaan FE; Rimm AA
    Lancet; 1983 Sep; 2(8351):663-7. PubMed ID: 6136805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relapsed acute lymphoblastic leukemia: similar outcomes for autologous and allogeneic marrow transplantation in selected children.
    Parsons SK; Castellino SM; Lehmann LE; Eickhoff CE; Tarbell NJ; Sallan SE; Weinstein HJ; Billett AL
    Bone Marrow Transplant; 1996 May; 17(5):763-8. PubMed ID: 8733695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome following late marrow relapse in childhood acute lymphoblastic leukemia.
    Chessells J; Leiper A; Rogers D
    J Clin Oncol; 1984 Oct; 2(10):1088-91. PubMed ID: 6593434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Marrow transplantation for children with acute lymphoblastic leukemia in second remission.
    Sanders JE; Thomas ED; Buckner CD; Doney K
    Blood; 1987 Jul; 70(1):324-6. PubMed ID: 3297205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autologous bone-marrow transplants compared with chemotherapy for children with acute lymphoblastic leukaemia in a second remission: a matched-pair analysis. The Berlin-Frankfurt-Münster Study Group.
    Borgmann A; Schmid H; Hartmann R; Baumgarten E; Hermann K; Klingebiel T; Ebell W; Zintl F; Gadner H; Henze G
    Lancet; 1995 Sep; 346(8979):873-6. PubMed ID: 7564672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Allogenic bone marrow transplantation versus autograft in acute lymphoblastic leukemia, in second remission in 113 children. Results of the Grupo Español de Transplante de Medula Niños (GETMON)].
    Badell I; Ortega JJ; Muñoz A; Bureo E; Madero L; Olivé T; Cubells J; Maldonado MS; Baro J; Díaz MA
    Sangre (Barc); 1996 Apr; 41(2):101-8. PubMed ID: 9045349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allogeneic bone marrow transplantation vs aggressive post-remission chemotherapy for children with acute myeloid leukemia in first complete remission. A prospective study from the French Society of Pediatric Hematology and Immunology (SHIP).
    Michel G; Leverger G; Leblanc T; Nelken B; Baruchel A; Landman-Parker J; Thuret I; Bergeron C; Bordigoni P; Esperou-Bourdeau H; Perel Y; Vannier JP; Schaison G
    Bone Marrow Transplant; 1996 Feb; 17(2):191-6. PubMed ID: 8640165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolated extramedullary relapse in children with acute lymphoblastic leukemia: a comparison between treatment results of chemotherapy and bone marrow transplantation. BFM Relapse Study Group.
    Borgmann A; Hartmann R; Schmid H; Klingebiel T; Ebell W; Göbel U; Peters C; Gadner H; Henze G
    Bone Marrow Transplant; 1995 Apr; 15(4):515-21. PubMed ID: 7655375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of marrow transplantation with chemotherapy for children with acute lymphoblastic leukemia in second or subsequent remission.
    Johnson FL; Thomas ED; Clark BS; Chard RL; Hartmann JR; Storb R
    N Engl J Med; 1981 Oct; 305(15):846-51. PubMed ID: 7024804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Allogeneic bone marrow transplantation in acute lymphoblastic leukemia of children. Analysis of prognostic factors. GEGMO (Bone Marrow Study Group) study].
    Bordigoni P; Vernant JP; Souillet G; Philippe N; Maraninchi D
    Arch Fr Pediatr; 1986 Dec; 43(10):765-8. PubMed ID: 3548632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction and prevention of relapse of acute lymphoblastic leukaemia after bone marrow transplantation.
    Barrett AJ; Joshi R; Kendra JR; Philips RH; Ashford R; Shaw PJ; Hugh-Jones K; Hobbs JR
    Br J Haematol; 1986 Sep; 64(1):179-86. PubMed ID: 3530314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.